Sage Therapeutic — Company Overview, News & Financial Data

Sage Therapeutics (NASDAQ:SAGE) is a biopharmaceutical company focused on the discovery, development, and commercialization of medicines designed to address disorders of the brain. The heart of Sage's mission lies in developing innovative therapies to enhance the lives of patients with central nervous system (CNS) disorders, which range from depression to neurological ailments. Sage's deep commitment to CNS disorders has fueled its drive towards groundbreaking research and the translation of its findings into therapeutic advancements. With a portfolio that includes both approved treatments and drugs under development, Sage Therapeutics strives not only for the advancement of medical science but also for providing hope and improved quality of life for patients grappling with challenging conditions. Through its dedication to innovation and patient care, Sage aims to redefine the treatment landscape for CNS disorders.